Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis | Zendy

AI Assistant Blog Pricing

Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.